A Study Evaluating the 24-Hour Intraocular Pressure Lowering Effect of Bimatoprost SR in Patients With Open-Angle Glaucoma or Ocular Hypertension
Conditions: Open-Angle Glaucoma; Ocular Hypertension Interventions: Drug: Bimatoprost SR; Drug: LUMIGAN Sponsor: Allergan Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials